TLX logo

TLX Telix Pharmaceuticals Limited

NASDAQ · Biotechnology · Healthcare

$8.37
-0.34 (-3.90%)

Telix Pharmaceuticals Limited is an Australian-based radiopharmaceutical company dedicated to pioneering molecularly targeted radiation (MTR) products. These innovations are developed for the diagnosis and treatment of various cancers and rare conditions, with its global presence encompassing Australia, Belgium, Japan, Switzerland, and the United States. The company's robust pipeline includes seve…

Market Cap: $2.84Btelixpharma.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
—
60d
50
5 mentions
—
90d
52
11 mentions
—
news: 11

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 1Sell 0Strong Sell 0
Avg price target$18+115.1%
Low $18Median $18High $18
Current Consensus

Revenue

$476.04M
$0.00$198.08M$396.16M$594.24M
Jan 1999Jun 2026

Analyst Estimates

FY2025
$0.01
$-0.01–$0.02
4 analysts
FY2026
$0.12+1554% YoY
$0.09–$0.19
6 analysts
FY2027
$0.07-41% YoY
$0.06–$0.08
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Christian Behrenbruch
Sector
Healthcare
Industry
Biotechnology
Employees
1,152
Beta
0.56
Country
AU
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.69
telixpharma.com